DAIHAN Scientific Co. Ltd (131220) — Cash Flow-to-Debt Ratio
DAIHAN Scientific Co. Ltd (131220) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of ₩361.12 Million could theoretically repay 0% of its total liabilities (₩13.84 Billion) in one year. See 131220 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
DAIHAN Scientific Co. Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for DAIHAN Scientific Co. Ltd across 12 annual periods. Also explore 131220 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for DAIHAN Scientific Co. Ltd (2012–2024)
Year-by-year debt coverage analysis for DAIHAN Scientific Co. Ltd. For market capitalisation and broader financial context, see 131220 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.16x | ₩3.99 Billion | ₩25.59 Billion | ▼ -19.4% |
| 2023 | 0.19x | ₩4.79 Billion | ₩24.80 Billion | ▼ -1.4% |
| 2022 | 0.20x | ₩4.51 Billion | ₩23.02 Billion | ▲ +5.8% |
| 2021 | 0.19x | ₩4.13 Billion | ₩22.29 Billion | ▼ -45.4% |
| 2020 | 0.34x | ₩5.35 Billion | ₩15.74 Billion | ▲ +125.6% |
| 2019 | 0.15x | ₩2.44 Billion | ₩16.20 Billion | ▼ -46.4% |
| 2018 | 0.28x | ₩3.76 Billion | ₩13.39 Billion | ▼ -21.0% |
| 2017 | 0.36x | ₩4.58 Billion | ₩12.89 Billion | ▲ +50.4% |
| 2016 | 0.24x | ₩4.12 Billion | ₩17.45 Billion | ▲ +361.2% |
| 2015 | 0.05x | ₩898.12 Million | ₩17.53 Billion | ▼ -63.1% |
| 2014 | 0.14x | ₩2.59 Billion | ₩18.66 Billion | ▲ +260.3% |
| 2012 | 0.04x | ₩565.94 Million | ₩14.69 Billion | — |